Cellectis S.A.

ALCLS

FR0010425595

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-02-09 am EST			Pre-market 01:05:01 am
3.190 ^EUR	+2.74%		3.200	+0.31%

Feb. 09	European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	MT
Feb. 05	European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading	MT

European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading

Published on 12/29/2025 at 11:16 am EST

MT Newswires

Latest news about Cellectis S.A.

Feb. 09	European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	MT
Feb. 05	European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading	MT
Feb. 04	European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	MT
Feb. 03	European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading	MT
Jan. 30	European Equities Traded in the US as American Depositary Receipts Edge Lower in Friday Trading; Up for Week	MT
Jan. 28	European Equities Traded in the US as American Depositary Receipts Fall Sharply in Wednesday Trading	MT
Jan. 26	European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	MT
Jan. 22	European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading	MT
Jan. 14	European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	MT
Jan. 13	European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading	MT
Dec. 30	European Equities Traded in the US as American Depositary Receipts Rise Tuesday	MT
Dec. 29	European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading	MT
Dec. 26	European Equities Traded in the US as American Depositary Receipts Little Changed in Friday Trading; Gains 2% for Week	MT
Dec. 23	European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading	MT
Dec. 22	European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	MT
Dec. 19	European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Slightly Higher for Week	MT
Dec. 18	European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading	MT
Dec. 16	European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading	MT
Dec. 16	Cellectis shares fall after arbitration in dispute with Servier
Dec. 15	Cellectis announces arbitral decision in dispute with Servier	RE
Dec. 15	Cellectis S.A. - Analyst/Investor Day
Dec. 12	European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Shares Still Up This Week	MT
Dec. 11	European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	MT
Dec. 10	European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading	MT
Dec. 09	European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading	MT

Cellectis S.A. is a clinical-stage biotechnology company using its pioneering TALEN® genome-editing technology to develop innovative therapies for the treatment of serious diseases. Cellectis S.A. is developing the first CAR T cell-based allogeneic immunotherapy therapeutics, inventing the concept of off-the-shelf, ready-to-use engineered CAR T cells for the treatment of cancer patients, and a platform for for the development of gene therapies in other therapeutic indications. Thanks to its fully in-house production capabilities, Cellectis S.A. is one of the few genome-editing companies to control the cell and gene therapy value chain from end to end.

Employees

219

Sector

Biotechnology & Medical Research

Calendar

Mar. 10 - Q4 2025 Earnings Release (Projected)

More about the company